MedPath

回音必集团安徽制药有限公司

Ownership
-
Established
1998-08-06
Employees
-
Market Cap
-
Website
www.huiyinbi.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

元胡止痛片

Approval Number
国药准字Z34020771
Approval Date
Jun 2, 2024
NMPA

益母草颗粒

Approval Number
国药准字Z34020785
Approval Date
Jun 2, 2024
NMPA

绿梅止泻颗粒

Approval Number
国药准字Z20026783
Approval Date
Jun 2, 2024
NMPA

天麻片

Approval Number
国药准字Z34020767
Approval Date
Dec 12, 2023
NMPA

橘红颗粒

Approval Number
国药准字Z20143005
Approval Date
Nov 3, 2023
NMPA

知柏地黄丸

Approval Number
国药准字Z34021038
Approval Date
Jun 15, 2020
NMPA

复方丹参片

Approval Number
国药准字Z34020764
Approval Date
May 19, 2020
NMPA

复方鱼腥草片

Approval Number
国药准字Z20044269
Approval Date
May 11, 2020
NMPA

健脾丸

Approval Number
国药准字Z34021035
Approval Date
May 8, 2020
NMPA

逍遥颗粒

Approval Number
国药准字Z20055022
Approval Date
May 8, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.